Armed with $137M fund, Signet launch­es hunt for a dozen new biotech plays

3 years ago
R&D

Trump nukes bio­phar­ma, and the fall­out is ra­dioac­tive

3 years ago
Bioregnum

Is Spin­raza worth $750K? Bio­gen says yes, spelling out re­duced death risk

3 years ago
Pharma
R&D

In­ves­ti­ga­tors sig­nal thumbs-up for an­tibi­ot­ic, prep an FDA pitch for OK

3 years ago
R&D

Failed Ni­valis pares down to a skele­ton crew as it launch­es a sal­vage op­er­a­tion

3 years ago
Pharma
R&D

Pfiz­er wants you. And you. And you. And you.

3 years ago
Deals

Bio­gen spin­off be­gins trad­ing to­day; New on­col­o­gy chief at As­traZeneca

3 years ago
Protocols

As Trump fin­gers phar­ma on drug prices, ex­ecs step up with the lat­est vows of self dis­ci­pline

3 years ago
Pharma

Vi­sion or voodoo? Biotech IPO mas­ter Vivek Ra­maswamy is still set­ting up new biotechs and hatch­ing more deals

3 years ago
IPOs
People

FDA re­jects Tesaro’s IV ver­sion of ro­lap­i­tant, cit­ing man­u­fac­tur­ing is­sues

3 years ago
Pharma

Cure­Vac’s lead mR­NA pro­gram flunks a crit­i­cal PhI­Ib study, rais­ing ques­tions for high-pro­file biotech uni­corns

3 years ago
R&D

Don­ald Trump promis­es to slash drug prices by bil­lions, pledg­ing ag­gres­sive fed­er­al bid­ding process

3 years ago
Pharma

Eli Lil­ly, Mer­ck add new com­bo al­liance; Gilead re­al­ly does want to fo­cus on M&A

3 years ago
Protocols

Dai­ichi Sankyo launch­es glob­al R&D re­struc­tur­ing, look­ing to slash costs in an over­haul

3 years ago
Pharma
R&D

In a stun­ner, Mer­ck leaps ahead of ri­vals with com­bo Keytru­da/chemo at­tack on lung can­cer

3 years ago
Pharma
R&D

Mer­ck KGaA splurges $230M on its pipeline, pay­ing Ver­tex for a slate of ear­ly-stage can­cer drugs

3 years ago
Pharma

A hun­gry Take­da con­tin­ues deal spree with $125M T cell pact, op­tion to buy

3 years ago
Pharma

Strug­gling Sarep­ta bounces back as an­a­lysts cheer the first trick­le of rev­enue for DMD drug

3 years ago
Pharma
R&D

Valeant auc­tions off Den­dreon, skin­care as­sets; Bay­er to col­lab­o­rate with the Uni­ver­si­ty of Pitts­burgh

3 years ago
Protocols

J&J In­no­va­tion ex­pands its biotech in­cu­ba­tor JLABS in­to Man­hat­tan

3 years ago
Pharma

Bio­gen CEO Michel Vounatsos re­groups and stakes out a BD plan for 2017

3 years ago
People
R&D

Se­cre­tive? Mod­er­na de­tails its pipeline strat­e­gy at JPM but at least one crit­ic bites back

3 years ago
R&D

Fresh from grab­bing Shire’s mR­NA work, RaNA dis­clos­es a $51M raise

3 years ago
Pharma

Kite lines up a JV in Chi­na while Dai­ichi Sankyo strikes $250M-plus deal to launch CAR-T drug in Japan

3 years ago
Pharma
R&D
First page Previous page 261262263264265266267 Next page Last page